Lipkis Sheree B MD - 60026 Glenview Nas, IL

Business Name: Lipkis Sheree B MD
Categorized In: Doctors
Address: 2150 Pfingsten Road # 1200, Glenview Nas, IL 60026
Phone Number: (847) 730-3983
Contact Person: Sheree Lipkis
Website Address: il-glenview.doctors.at
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 1995
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Brodsky Amy L MD - Glenview Nas, IL 60026
Reimer Meredith MD - Glenview Nas, IL 60026
Holub David C MD - Glenview Nas, IL 60026
Uhler Meike L MD - Glenview Nas, IL 60026
Ellman Carol MD - Glenview Nas, IL 60026
Rapisarda John J MD - Glenview Nas, IL 60026
Moise Jacob MD - Glenview Nas, IL 60026
Vaughn Ryan C MD - Glenview Nas, IL 60026
Kells Kenneth G MD - Glenview Nas, IL 60026
Children's Gastroenterolgy Spc - Glenview Nas, IL 60026
Garvey Timothy - Glenview Nas, IL 60026
Schneider Daphne MD - Glenview Nas, IL 60026
Zaacks Laura MD - Glenview Nas, IL 60026
Flom L Suzanne MD - Glenview Nas, IL 60026
Wolff Allan P MD - Glenview Nas, IL 60026
Kudrna James C MD - Glenview Nas, IL 60026
Miller Ronald MD - Glenview Nas, IL 60026
Miller Jeremy MD - Glenview Nas, IL 60026
Wade Elaine L MD - Glenview Nas, IL 60026
Rothenberg Albert MD - Glenview Nas, IL 60026

Lipkis Sheree B MD provides professional Doctors from its single location at the coordinates 42.09546,-87.84923.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 1995, the company can now be visited at 2150 Pfingsten Road # 1200, Glenview Nas, Illinois 60026 or contacted through representative Sheree Lipkis at (847) 730-3983.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Lipkis Sheree B MD through its company website at il-glenview.doctors.at. Engage with this business on its social media platforms through on Twitter and on Facebook.